Pfizer Inc
PFE· NYSE
Released Aug 4, 2026, before the open
10-Q filed Aug 4, 2026, 37 days after period end · 0000078003-26-000095
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $15.03B | $14.65B | $13.28B | $13.01B |
| Net Income | -$248.00M | $2.91B | $41.00M | $2.33B |
| EPS Diluted |
Pfizer Inc · CIK 78003 · Engraved from SEC EDGAR
| -$0.04 |
| $0.51 |
| $0.01 |
| $0.41 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.